The DOI matches its Crossref record; 155 of the 158 references it cites were found in a registry or an index.
Autoimmune hepatitis and its variant syndromes
Open accessAbstract
Autoimmune hepatitis and its variant syndromes Autoimmune hepatitis (AIH) is characterised by female predominance, interface hepatitis, hypergammaglobulinaemia, and autoantibodies.1 2 Typically, the disease responds well to corticosteroid therapy, and clinical, laboratory, and histological remission can be achieved in 65% of patients within 18 months.3 4 Among Caucasoid Northern Europeans, its mean annual incidence is 1.9 per 100 000, and its point prevalence is 16.9 per 100 000. 5 In the USA, AIH aVects 100 000-200 000 individuals.6 It accounts for 2.6% of the liver transplants in the European Liver Transplant Registry 7 and 5.9% of liver transplants in the USA.8 Classical autoimmune hepatitis Three types of AIH have been proposed based on immunoserological findings but only two types have mutually exclusive autoantibodies and diVerent clinical profiles.9 Type 1 AIH is the most common form of the disease worldwide and is associated with antinuclear antibodies (ANA) and/or smooth muscle antibodies (SMA).It aVects all age groups and is associated with human leucocyte antigen (HLA) DR3 (DRB1*0301) and DR4 (DRB1*0401) in Caucasoid Northern European and North American patients.10 11 DRB1*0301 and DRB1*0401 influence disease expression and behaviour as well as susceptibility.Caucasoid patients with type 1 AIH and DRB1*0301 are younger, and have a higher frequency of treatment failure, 12 relapse after drug withdrawal, 13 and requirement for liver transplantation than patients with other alleles.14 In contrast, patients with DRB1*0401 are typically older, frequently have concurrent autoimmune diseases, and respond better to corticosteroids than counterparts with DRB1*0301.15 Type 2 AIH aVects mainly children and is characterised by antibodies to liver/kidney microsome type 1 (anti-LKM1).16 The target autoantigen of type 2 AIH is the cytochrome mono-oxygenase P450 IID6 (CYP2D6), 17 18 and five antigenic sites located between [257][258][259][260][261][262][263][264][265][266][267][268][269][373][374][375][376][377][378][379][380][381][382][383][384][385][386][387][388][389][410][411][412][413][414][415][416][417][418][419][420][421][422][423][424][425][426][427][428][429] The main antigenic site is the peptide sequence 257-269 and the second most recognised sequence is 321-351.Most patients with type 2 AIH have anti-LKM1 that react against one of these short linear sequences, 19 20 and this reactivity distinguishes them from those patients with anti-LKM1 and chronic hepatitis C. 21 22 Susceptibility to type 2 AIH appears to relate to DRB1*0701, 23 24 but HLA B14, DR3, and C4A-QO have also been incriminated.25 Immune diseases (especially vitiligo, autoimmune thyroiditis, and insulin dependent diabetes mellitus) and organ specific autoantibodies (antibodies to thyroid, parietal cell, and/or islets of Langerhans) occur commonly.16 Initial studies that suggested a poorer outcome in type 2 than in type 1 AIH 16 have not been substantiated, and both type 1 and type 2 disease respond comparably to corticosteroids.26 27 Both types can have an acute, even fulminant, presentation, and prompt recognition and treatment are necessary to control inflammatory activity.[28][29][30] AIH in association with anti-LKM1 has also been described in 15% of patients with autoimmune polyglandular syndrome type 1 (APS1).[31][32][33] This syndrome is caused by a single gene mutation located on chromosome 21q22.3.34 35 The APS1 gene encodes for a transcription
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A small minority of patients with AIH are AMA +ve, typically in the context of other AIH-characteristic autoantibodies.268 269”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [268]
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Self-citationClassification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M. A., Hoofnagle, J. H., Manns, M. P., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,591
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Aaltonen, J., Björses, P., Perheentupa, J., Horelli‐Kuitunen, N., Palotie, A. V., Peltonen, L., Lee, Y. S., Francis, F., Henning, S., Thiel, C. S., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-399 · Cited by 1,214
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Ahonen, P., Myllärniemi, S., Sipilä, I., & Perheentupa, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222601 · Cited by 1,068
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746
Gregorio, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22131 · Cited by 692
Autoimmune Hepatitis in Childhood: A 20–Year Experience
Gregorio, G. V., Portmann, B. C., Reid, F., Donaldson, P. T., Doherty, D. G., McCartney, M., Mowat, A. P., Vergani, D., & Mieli‐Vergani, G. (1997) · Hepatology · doi:10.1002/hep.510250308 · Cited by 662
Zinkernagel, R. M. (1996) · Science · doi:10.1126/science.271.5246.173 · Cited by 647
Flagged first, then by citations
3 of the 158 references couldn’t be matched to a known paper.
Research works printed but not linked: 12
- 10.1016/0270-9139(91)92567-R · DOI
- 10.1016/0270-9139(93)90498-C · DOI
- 10.1016/0270-9139(91)90225-K · DOI
- 10.1016/0270-9139(95)90170-1 · DOI
- 10.1016/0270-9139(95)90507-3 · DOI
- Lunel, 1992, Liver/kidney microsome antibody type 1 and hepatitis C virus infection., Hepatology, 16, 630, 10.1002/hep.1840160304 · DOI
- 10.1016/0270-9139(94)90281-X · DOI
- 10.4065/74.5.454 · DOI
- 10.1016/0270-9139(94)90250-X · DOI
- 10.1016/0270-9139(95)90139-6 · DOI
- 10.1016/0270-9139(95)90150-7 · DOI
- 10.1016/0270-9139(93)90499-D · DOI
Cited by
Sorted by citations
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
Self-citationDiagnosis and treatment of autoimmune hepatitis
Czaja, A. J., & Freese, D. K. (2002) · Hepatology · doi:10.1053/jhep.2002.34944 · Cited by 576
Self-citationBoberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Current and novel immunosuppressive therapy for autoimmune hepatitis
Heneghan, M. A., & McFarlane, I. G. (2002) · Hepatology · doi:10.1053/jhep.2002.30991 · Cited by 207
Chazouillères, O., Wendum, D., Serfaty, L., Rosmorduc, O., & Poupon, R. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.017 · Cited by 194
Overlap syndromes among autoimmune liver diseases
Rust, C., & Beuers, U. H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3368 · Cited by 158
Czaja, A. J. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328034f234 · Cited by 147
Self-citationPrevalence and epidemiology of autoimmune hepatitis
Boberg, K. M. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00021-1 · Cited by 138
Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance
Czaja, A. J. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.33485 · Cited by 101
Self-citationCarpenter, H. A., & Czaja, A. J. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00022-3 · Cited by 97
Self-citationUnnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory
Kwok, J., & Jones, B. M. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.021691 · Cited by 94
Diagnosis and Management of the Overlap Syndromes of Autoimmune Hepatitis
Czaja, A. J. (2013) · Canadian Journal of Gastroenterology · doi:10.1155/2013/198070 · Cited by 88
Self-citationDiagnostic considerations for cholestatic liver disease
Pollock, G., & Minuk, G. Y. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13738 · Cited by 88
Performance Parameters of the Conventional Serological Markers for Autoimmune Hepatitis
Czaja, A. J. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1501-1 · Cited by 81
Self-citationThe Overlap Syndromes of Autoimmune Hepatitis
Czaja, A. J. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2367-1 · Cited by 76
Self-citationDifficult treatment decisions in autoimmune hepatitis
Czaja, A. J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i8.934 · Cited by 74
Self-citationWatson, P. (2003) · The Veterinary Journal · doi:10.1016/s1090-0233(03)00118-7 · Cited by 72
Current concepts in autoimmune hepatitis
Czaja, A. J. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32081-2 · Cited by 68
Self-citationCholestatic phenotypes of autoimmune hepatitis
Czaja, A. J. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.08.039 · Cited by 63
Self-citationPapamichalis, P. A., Zachou, K., Koukoulis, G. Κ., Veloni, A., Karacosta, E. G., Kypri, L., Mamaloudis, I., Gabeta, S., Rigopoulou, E. I., Lohse, A. W., et al. (2007) · Journal of Autoimmune Diseases · doi:10.1186/1740-2557-4-3 · Cited by 62
Gheorghe, L. S., Iacob, S., Gheorghe, C., Iacob, R. A., Simionov, I. I., Vădan, R., Becheanu, G., Pârvulescu, I., & Toader, C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200406000-00012 · Cited by 59
Czaja, A. J., Shums, Z., & Norman, G. L. (2002) · Autoimmunity · doi:10.1080/0891693021000054101 · Cited by 59
Self-citationSignificance of antibodies to soluble liver antigen/liver pancreas: a large French study
Eyraud, V., Chazouilleres, O., Ballot, E., Corpechot, C., Poupon, R., & Johanet, C. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.01986.x · Cited by 58
Current Concepts in the Diagnosis, Pathogenesis, and Treatment of Autoimmune Hepatitis
Al-Khalidi, J. A., & Czaja, A. J. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.12.1237 · Cited by 45
Self-citationFarias, A. Q., Gonçalves, L. L., Bittencourt, P. L., De Melo, E. S., Abrantes‐Lemos, C. P., Porta, G., Nakhle, M. C., Carrilho, F. J., & Cancado, E. L. R. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04130.x · Cited by 43
Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study
Efe, C., Özaslan, E., Wåhlin, S., Pürnak, T., Muratori, L., Quarneti, C., Yüksel, O., & Muratori, P. (2012) · Liver International · doi:10.1111/liv.12022 · Cited by 40
Autoimmune hepatitis in special patient populations
Czaja, A. J. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.09.011 · Cited by 39
Self-citationMR Imaging Findings in Autoimmune Hepatitis: Correlation with Clinical Staging
Bilaj, F., Hyslop, W. B., Rivero, H. J., Fırat, Z., Vaidean, G. D., Shrestha, R., Woosley, J. T., & Semelka, R. C. (2005) · Radiology · doi:10.1148/radiol.2363041262 · Cited by 38
Overlap Syndromes of Cholestatic Liver Diseases and Auto-Immune Hepatitis
Schramm, C., & Lohse, A. W. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:2:105 · Cited by 37
Autoimmune hepatitis preceded by acute hepatitis A infection
Skoog, S. M., Rivard, R. E., Batts, K. P., & Smith, C. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04107-2 · Cited by 32
Autoimmune Hepatitis Overlap Syndromes and Liver Pathology
Czaja, A. J., & Carpenter, H. A. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.01.008 · Cited by 31
Self-citationTotal serum bilirubin as a negative prognostic factor in idiopathic canine chronic hepatitis
Selgas, A. G., Bexfield, N., Scase, T. J., Holmes, M. A., & Watson, P. (2014) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/1040638713520602 · Cited by 29
Gisbert, J. P., Jones, E. A., Pajares, J. M., & Moreno‐Otero, R. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01381.x · Cited by 24
Bril, F. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.001 · Cited by 24
Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience
Karakoyun, M., Ecevıt, Ç. Ö., Kılıçoğlu, E., Aydoğdu, S., Yağcı, R. V., & Özgenç, F. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000648 · Cited by 23
REVIEW: Overlap Syndromes of Autoimmune Hepatitis: What Is Known So Far
Durazzo, M., Premoli, A., Fagoonee, S., & Pellicano, R. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1022597210629 · Cited by 18
Overlap syndrome of autoimmune chronic liver diseases: MRI findings
Hyslop, W. B., Kierans, A. S., Leonardou, P., Fritchie, K., Darling, J. M., El‐Azzazi, M., & Semelka, R. C. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22048 · Cited by 17
Cazanave, C., Rakotondravelo, S. J. B., Morlat, P., Blanco, P., Bonnet, F., & Beylot, J. (2006) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2006.01.016 · Cited by 17
Diagnosis and Treatment of Autoimmune Hepatitis
Luxon, B. A. (2008) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2008.02.002 · Cited by 16
Zepeda-Gómez, S., Montaño‐Loza, A. J., Zapata-Colindres, J. C., Paz, F., Olivera-Martinez, M. A., López-Reyes, A. G., Granados, J., & Vargas‐Alarcón, G. (2009) · Immunological Investigations · doi:10.1080/08820130902846282 · Cited by 15
Seronegative autoimmune hepatitis presenting after diagnosis of coeliac disease: a case report
Quail, M. A., Russell, R. K., Bellamy, C. O. C., Mieli‐Vergani, G., & Gillett, P. M. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282fa1400 · Cited by 14
Hépatites auto-immunes : diagnostic immunologique
Brahim, I., Brahim, I., Hazime, R., & Admou, B. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.08.012 · Cited by 14
Viral Diseases of the Liver in Children: Diagnostic and Differential Diagnostic Considerations
White, F. V., & Dehner, L. P. (2004) · Pediatric and Developmental Pathology · doi:10.1007/s10024-004-8101-z · Cited by 14
Czaja, A. J. (2004) · Elsevier eBooks · doi:10.1016/b0-12-386860-2/00048-4 · Cited by 14
Self-citationHunter, M. L., Loughrey, M. B., Gray, M., Ellis, P., McDougall, N., & Callender, M. E. (2011) · PubMed Central · Cited by 13
Autoantibodies in chronic liver disease.
Ghonaim, M., Alghamdi, A. S., El-Bana, H., Bakr, A. A., Ghoneim, E. M., El-Edel, R. H., Hassona, M., Shoeib, S. A. A., & Allam, H. (2005) · PubMed · Cited by 13
Type 1 autoimmune hepatitis revealed by a dysphonia related to cricoarytenoid arthritis
Loukili, N. (2003) · QJM · doi:10.1093/qjmed/hcg022 · Cited by 10
Hépatites auto-immunes : actualités diagnostiques et thérapeutiques
Corpechot, C., & Chazouillères, O. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.05.015 · Cited by 10
Trauner, M., & Boyer, J. L. (2002) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200205000-00005 · Cited by 9
Overlap syndromes: An emerging diagnostic and therapeutic challenge
Malhotra, S., & Dhiman, P. (2014) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.145316 · Cited by 8
A girl with type 1 diabetes and a yellowish appearance: Figure 1
Hovinga, I. C. L. K., Stam, E. D., Mearin, M. L., & Mul, D. (2010) · BMJ Case Reports · doi:10.1136/bcr.04.2010.2899 · Cited by 8
Czaja, A. J. (2002) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200205000-00007 · Cited by 8
Self-citationDuclos‐Vallée, J., Ballot, E., Huguet‐Jacquot, S., & Johanet, C. (2005) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(05)82207-9 · Cited by 8
Bhadoria, A. S., Kedarisetty, C. K., Bihari, C., Kumar, G., Jindal, A., Bhardwaj, A., Shasthry, V., Benjamin, J., Kumar, M., & Sarin, S. K. (2018) · Liver International · doi:10.1111/liv.13958 · Cited by 7
Gradwell, D., & Rainford, D. J. (2006) · CRC Press eBooks · doi:10.1201/b13238-151 · Cited by 7
Garg, D. K., Nagar, A. M., Philips, S., Takahashi, N., Prasad, S. R., Shanbhogue, K., & Sahani, D. V. (2011) · Abdominal Imaging · doi:10.1007/s00261-011-9759-0 · Cited by 6
Tsou, Y., & Yeh, C. (2003) · PubMed · Cited by 6
Silva, S. D., & Neuberger, J. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01258.x · Cited by 6
Current topics relating to autoimmune hepatitis diagnosis and therapy
Takahashi, H. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00240.x · Cited by 5
The pediatric medical liver biopsy: indications, procedures, and histopathology
Sergi, C. M. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2607575 · Cited by 4
Auto-anticorps et pathologies hépatiques
Johanet, C., Huguet‐Jacquot, S., Eyraud, V., & Ballot, E. (2006) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(06)80496-x · Cited by 4
Autoimmune hepatitis: Diagnosis, treatment, and prognosis
Luxon, B. A. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0068-7 · Cited by 4
Autoimmune Hepatitis ; Recent Korean Trend
Lee, Y. S. (2005) · Journal of the Korean Medical Association · doi:10.5124/jkma.2005.48.5.456 · Cited by 3
Sawadpanich, K., Promasen, P., Mairiang, P., Sukeepaisarnjareon, W., Sangchan, A., Suttichaimongkol, T., Tangvoraphonkchai, K., & Foocharoen, C. (2023) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s410165 · Cited by 2
Diagnostic Approach to Autoimmune Hepatitis
Lim, K., & Park, J. G. (2022) · Korean Journal of Medicine · doi:10.3904/kjm.2022.97.1.33 · Cited by 2
Barrientos, M. A., Díaz-Coronado, J. C., Castrillón, J. C. O., Zapata, J. C. R., Arango, G. C., Restrepo, J. C., & Gómez, J. R. M. (2005) · IATREIA · doi:10.17533/udea.iatreia.4145 · Cited by 2
Use of immunosuppression in non-transplant hepatology
Ronca, V., Bozward, A. G., & Oo, Y. H. (2021) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2021.101760 · Cited by 2
Braga, L., Altun, E., Armao, D. M., & Semelka, R. C. (2015) · Wiley eBooks · doi:10.1002/9781119012979.ch2 · Cited by 2
Ducarme, G., Bernuau, J., Thuillier, C., Ceccaldi, P., & Luton, D. (2010) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(10)70777-3 · Cited by 1
Martínez, Ó. N., Ibáñez, I. M., Bravo-Burguillos, E. R., Sotillos, A. E., & Sosa, J. C. E. (2012) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2012.07.007 · Cited by 1
Marta, S., Nowak‐Markwitz, E., Mirosław, S., Spaczyński, M., Linke, K., & Zeromski, J. (2008) · PubMed · Cited by 1
Adult idiopathic cholestasis: a condition more common in the Canadian Inuit?
Minuk, G. Y., Pollock, G., & Uhanova, J. (2017) · International Journal of Circumpolar Health · doi:10.1080/22423982.2017.1388104 · Cited by 1
Gossard, A. A., & Lindor, K. D. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547416.011 · Cited by 1
Czaja, A. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00088-3 · Cited by 1
Self-citationHughes, S. J., & Heneghan, M. A. (2009) · Wiley eBooks · doi:10.1002/9781444322682.ch10 · Cited by 1
11 Auto-immuunhepatitis en overlapsyndromen
van Hoek, B., van Nieuwkerk, C. M. J., & Jarbandhan, S. V. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7437-3_11
Dancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_23
McFarlane, I. G. (2004) · Principles of medical biology · doi:10.1016/s1569-2582(04)15015-0
Terrabuio, D. R. B. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2008.tde-28052008-142223
Niveis plasmáticos de pivka-II em pacientes com hepatite autoimune
Sundell, M. D. O. T. (2011) · doi:10.47749/t/unicamp.2011.816202
Autoanticorpset hépatites virales
Johanet, C. (2006) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(06)80318-7
Autoimmune Cholangitis: A Variant Syndrome of Autoimmune Hepatitis
Sharma, B., Raina, S., & Sharma, R. (2014) · Case Reports in Hepatology · doi:10.1155/2014/501530
Hépatites d'étiologie inconnue
Chemin, I., Merle, P., Paraná, R., & TREPO, C. G. (2004) · EMC - Hépatologie · doi:10.1016/j.emchep.2004.01.001
Cas clinique: une succession de maladies autoimmunes.
Duclos‐Vallée, J. (2007) · Gastroentérologie Clinique et Biologique
Overlap Syndromes of Primary Sclerosing Cholangitis
Czaja, A. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-40908-5_4
Self-citationAutoimmune Liver Diseases: Overlap Syndromes
Czaja, A. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_18
Self-citation(2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-3661-6.00062-6
Une succession de maladies autoimmunes
Duclos‐Vallée, J. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)89389-4
Autoimmune Hepatitis Variant: Overlap Syndrome with Primary Biliary Cholangitis
Ergün, U., Kuscu, B., Ak, M. N., Turan, Ö. F., Avsar, E. N., Alp, B., Ürk, A., Özkan, B., & Çağlar, E. (2019) · International Journal of Scientific and Technological Research · doi:10.7176/jstr/5-6-07
Dancygier, H. (2003) · Springer eBooks · doi:10.1007/978-3-642-55902-0_25
Czaja, A. J. (2004) · doi:10.1007/978-1-4615-6502-4_3
Self-citationHépatites d'étiologie inconnue
Chemin, I., Merle, P., Paraná, R., & TREPO, C. G. (2004) · EMC - Hépatologie · doi:10.1016/s1155-1976(04)31601-3
Dancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_18
Ducarme, G., Schnee, M., & Dochez, V. (2016) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(16)77884-2
Arthur, M. J. P. (2002) · Medicine · doi:10.1383/medc.30.12.53.28529
AUTOIMUNINIŲ KEPENŲ LIGŲ PERSIDENGIMO SINDROMAI: DIAGNOSTIKA IR GYDYMO GALIMYBĖS
Janonytė, U., Gerasimovič, G., & Kiudelienė, E. (2024) · Health Sciences · doi:10.35988/sm-hs.2024.102
Yang, D., & Wang, G. (2025) · Hepatology International · doi:10.1007/s12072-025-10967-4
Metadata
- Authors
- BEN-ARI, Z., & CZAJA, A. J.
- Affiliations
- Liver Transplant Unit, Rabin Medical Center
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2001-10-01
- Volume
- 49
- Issue
- 4
- Pages
- 589-594
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC1728469
- OpenAlex
- W1982477121
- Cited by
- 102
- References
- 158
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 4
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gut (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- autoimmune hepatitis, type 1 autoimmune hepatitis, type 2 autoimmune hepatitis, HLA-DRB1, HLA-DR3, HLA-DR4, anti-LKM-1 antibodies, CYP2D6
- MeSH terms
- Adult, Algorithms, Child, Female, HLA Antigens, Humans, Male, Syndrome, Hepatitis, Autoimmune
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
